Management of Metformin in Pregestational Diabetes Controlled with Insulin

Introduction to Metformin Use

• The American Diabetes Association recommends that insulin should continue as the first-line treatment for patients with pregestational diabetes controlled with insulin during pregnancy, and not be changed to metformina, as insulin is the preferred and recommended agent for managing type 2 pregestational diabetes in pregnancy 1

Considerations for Metformin as an Alternative

• Metformin should only be considered as a second-line agent in very specific circumstances when insulin cannot be used safely or effectively, such as in cases of cost barriers, language barriers, comprehension problems, or cultural factors that interfere with insulin acceptance 1, 4

Prioritizing Insulin over Metformin

• Metformin crosses the placenta freely, resulting in cord blood levels equal to or higher than maternal levels, whereas insulin does not cross the placenta and has the most robust safety data 1, 3, 4

Concerns about Offspring

• Long-term follow-up studies reveal concerning metabolic effects in children exposed to metformin in utero, including higher weight, waist-to-height ratio, and waist circumference compared to those exposed to insulin 1, 3
• Meta-analyses demonstrate that metformin exposure results in smaller neonates with accelerated postnatal growth, leading to higher BMI in childhood 1, 3, 4

Limitations of Metformin Efficacy

• Substantial treatment failure rates: 14-46% of patients initially treated with metformin require supplemental insulin to achieve adequate glycemic control 1, 3

Specific Contraindications for Metformin in Pregnancy

• Metformin should not be used in patients with hypertension, preeclampsia, risk of intrauterine growth restriction, or suspected placental insufficiency 4

Clinical Decision Algorithm

• For pregestational type 2 diabetes, continue insulin as the first-line treatment throughout pregnancy, and consider metformin only if the patient cannot safely or effectively use insulin due to specific reasons 1, 2, 3
• For pregestational type 1 diabetes, insulin is mandatory, and metformin is not a treatment option 1

Special Consideration: Polycystic Ovary Syndrome (PCOS)

• If a patient was taking metformin to induce ovulation for PCOS, discontinue metformin at the end of the first trimester once pregnancy is confirmed 2, 4

Common Errors to Avoid

• Do not switch from insulin to metformin simply because the patient prefers oral medication - fetal safety should be prioritized 2, 3
• Do not use metformin for prevention of gestational diabetes in high-risk women with obesity or PCOS - meta-analyses show it does not reduce risk 1, 3

Summary of Guideline Position

• The American Diabetes Association clearly states that insulin is the preferred and recommended pharmacological agent for managing type 2 pregestational diabetes in pregnancy, and metformin should only be considered as a second-line alternative in specific circumstances when insulin cannot be used safely or effectively 1, 2, 3, 4